Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Single use Bioreactors Market is projected to grow at a CAGR of ~17%, till 2035, claims Roots Analysis

This image opens in the lightbox

News provided by

Roots Analysis

31 Aug, 2023, 16:45 GMT

Share this article

Share toX

Share this article

Share toX

Owing to the rising demand for efficacious biotherapeutics and multiple benefits of single use bioprocessing systems, the biopharmaceutical industry is gradually shifting its focus from conventional bioreactors to disposable bioreactors with advanced features

LONDON, Aug. 31, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Single use Bioreactors Market, 2023-2035" report to its list of offerings.

Single use bioreactors offer various advantages over conventional technologies, such as ease of installation, increased efficiency of the biomanufacturing process, operational flexibility, reduced risk of cross contamination, less energy and water consumption. In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the conventional stainless-steel bioreactors, manufacturers prefer to use single use bioreactors, in order to ensure the development of high-quality biologics.           

To order this 350+ page report, which features 120+ figures and 160+ tables, please visit 

https://www.rootsanalysis.com/reports/single use-bioreactors-market.html

Key Market Insights

Presently, more than 60 players claim to offer single use bioreactors

This segment of the industry is dominated by the presence of players (38%) established before 2001, followed by companies established post-2015 (18%). It is worth mentioning that 16% of the players established post-2015 are small companies (2-50 employees).

Close to 260 single use bioreactors are offered by various companies across the globe

Majority of the single use bioreactors (57%) are stirred tank bioreactors using agitation mechanism. Further, most of the single use bioreactors are suitable for processing mammalian cell culture and 90% of the bioreactors are capable of culturing more than one type of cell.

Till 2023, close to 80 partnerships have been established in the single use bioreactors domain

Of these, close to 30% deals were inked in the last three years. Majority of the instances captured in the report were supply agreements (27%). In addition, more than 55% of deals have been inked by players to supply stirred tank single use bioreactors for biomanufacturing.

The market for single use bioreactors is likely to grow at an annualized rate of ~17% during 2023-2035

The current market is driven by stirred tank bioreactors, which hold around 70% share of the overall single use bioreactors market; this trend is unlikely to change in the foreseen future as well. Further, in terms of scale of operation, bioreactors designed for commercial scale operations capture major share (55%) of the market in 2035.

Europe and Asia-Pacific are expected to capture close to 60% market share by 2035

In terms of type of biologics synthesized, vaccines and monoclonal antibodies are expected to capture around 50% of the total single use bioreactors market in 2035. Further, close to 65% of the single use bioreactors market is captured by biopharmaceutical / pharmaceutical industries.

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/single use-bioreactors-market/request-sample.html

Key Questions Answered

  • What is single use bioreactor?
  • What is the market size of single use bioreactors?
  • What are the factors driving the single use bioreactors market?
  • Who are the key players in single use bioreactors market?
  • Which region has the largest share in single use bioreactors market?
  • Which type of single use bioreactor has the largest share in the global single use bioreactor market?
  • Which are the leading market segments in global single use bioreactor market, in terms of type of biologic synthesized?
  • What type of partnerships are taking place in the single use bioreactors market?
  • What is the growth rate of single use bioreactors market?

The financial opportunity within the single use bioreactors market has been analyzed across the following segments:

  • Type of Bioreactor
    • Stirred Tank Bioreactors
    • Wave-Induced Bioreactors
    • Others Bioreactors
  • Scale of Operation
    • Lab
    • Clinical
    • Commercial
  • Type of Cell Culture
    • Mammalian
    • Insect
    • Microbial
    • Viral
    • Plant
    • Bacterial
  • Type of Biologics Synthesized
    • Autoimmune disorders
    • Vaccine
    • Monoclonal Antibody
    • Recombinant Protein
    • Stem Cell
    • Cell Therapy
    • Gene Therapy
  • End-Users
    • Biopharmaceutical / Pharmaceutical Industries
    • Academic / Research Institutes
  • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and North Africa
    • Latin America

The report features inputs from eminent industry stakeholders, according to whom, the increase in the demand for cell and gene therapies is driving the growth of the single use bioreactors market. The report includes detailed transcripts of discussions held with the following experts:

  • Shane Kilpatrick (Founder and Chief Executive Officer, Membio)
  • Justin Cesmat (Manager, Bioprocessing, Distek)
  • Bradley Maykow (Quality and Products Manager, Refine Technology)
  • Per Stobbe (Chief Executive Officer, CerCell)
  • Torsten Due Bryld (Global Director of Sales Support, CelVivo)

The research also includes detailed profiles of key players (listed below) engaged in offering single use bioreactors; each profile features a brief overview of the company, its financial information (if available), details on product portfolio, recent developments and an informed future outlook.

  • Applikon Biotechnology
  • Biolinx Labsystems
  • Celartia
  • Cell Culture Company
  • Cellexus
  • Cercell
  • CESCO Bioengineering
  • Cytiva
  • Eppendorf
  • Merck Millipore
  • Pall Corporation
  • PBS Biotech
  • PerfuseCell
  • ProlifeCell
  • Sartorius Stedim Biotech
  • Solaris Biotech
  • Synthecon
  • Thermo Fisher Scientific

For additional details, please visit 

https://www.rootsanalysis.com/reports/single use-bioreactors-market.html

You may also be interested in the following titles:

1.  Medical Drones Market: Industry Trends and Global Forecasts, 2023-2035

2.  Automated Liquid Handling Systems Market - Focus on Automated Pipetting Systems and Automated Microplate Washers: Industry Trends and Global Forecasts, 2023-2035

3.  Medical Polymers Market: Industry Trends and Global Forecasts, 2023-2035

4.  Global Bioreactors and Fermenters Market: Industry Trends and Global Forecasts, 2023-2035

5.  Global Filtration Market: Industry Trends and Global Forecasts, 2023-2035

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com 

Logo - https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.